MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Intuitive Surgical Inc

Open

BrancheGesundheitswesen

506.57 0.98

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

503.3

Max

513.24

Schlüsselkennzahlen

By Trading Economics

Einkommen

123M

688M

Verkäufe

374M

2.4B

KGV

Branchendurchschnitt

72.947

57.333

EPS

2.21

Gewinnspanne

28.506

Angestellte

15,638

EBITDA

116M

810M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+16.53% upside

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-39B

168B

Vorheriger Eröffnungskurs

505.59

Vorheriger Schlusskurs

506.57

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

Intuitive Surgical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Apr. 2025, 20:55 UTC

Ergebnisse

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23. Jan. 2025, 21:41 UTC

Ergebnisse

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21. Jan. 2025, 18:37 UTC

Akquisitionen, Fusionen, Übernahmen

Intuitive to Establish Direct Presence in Europe With Acquisition

18. Okt. 2024, 15:22 UTC

Ergebnisse
Wichtige Markttreiber

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17. Okt. 2024, 21:33 UTC

Ergebnisse
Wichtige Markttreiber

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17. Okt. 2024, 20:56 UTC

Ergebnisse

Intuitive Surgical Posts 3Q Revenue Growth

22. Apr. 2025, 20:13 UTC

Ergebnisse

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q EPS $1.92 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Net $698.4M >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22. Apr. 2025, 20:05 UTC

Ergebnisse

Intuitive Surgical 1Q Rev $2.25B >ISRG

24. Jan. 2025, 21:17 UTC

Ergebnisse

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24. Jan. 2025, 18:18 UTC

Ergebnisse

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24. Jan. 2025, 13:11 UTC

Top News

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24. Jan. 2025, 09:51 UTC

Heiße Aktien

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23. Jan. 2025, 21:10 UTC

Ergebnisse

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23. Jan. 2025, 21:09 UTC

Ergebnisse

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23. Jan. 2025, 21:09 UTC

Ergebnisse

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q Rev $2.41B >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q Net $685.7M >ISRG

23. Jan. 2025, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q EPS $1.88 >ISRG

15. Jan. 2025, 17:27 UTC

Ergebnisse

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6. Jan. 2025, 12:00 UTC

Top News

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18. Okt. 2024, 15:59 UTC

Ergebnisse

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18. Okt. 2024, 15:38 UTC

Ergebnisse

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18. Okt. 2024, 13:28 UTC

Ergebnisse

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17. Okt. 2024, 21:18 UTC

Ergebnisse
Wichtige Markttreiber

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Peer-Vergleich

Kursveränderung

Intuitive Surgical Inc Prognose

Kursziel

By TipRanks

16.53% Vorteil

12-Monats-Prognose

Durchschnitt 592.13 USD  16.53%

Hoch 675 USD

Tief 470 USD

Basierend auf 18 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Intuitive Surgical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

18 ratings

15

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

489.52 / 517.31Unterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.